Detalhe da pesquisa
1.
Long-term pasireotide therapy in acromegaly: extensive real-life experience of a referral center.
J Endocrinol Invest
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532073
2.
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogs.
J Endocrinol Invest
; 47(3): 683-697, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37695461
3.
Circulating myomiRNAs as biomarkers in patients with Cushing's syndrome.
J Endocrinol Invest
; 47(3): 655-669, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682493
4.
Control of acromegaly in more than 90% of patients after 10 years of pegvisomant therapy: an European referral centre real-life experience.
J Endocrinol Invest
; 46(5): 1027-1038, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892739
5.
Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile.
J Endocrinol Invest
; 46(12): 2481-2492, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204690
6.
Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial.
J Endocrinol Invest
; 45(5): 941-961, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973154
7.
Metabolic syndrome in the era of COVID-19 outbreak: impact of lockdown on cardiometabolic health.
J Endocrinol Invest
; 44(12): 2845-2847, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34037973
8.
Increased risk of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a three-year longitudinal study with phalangeal QUS measurements.
J Biol Regul Homeost Agents
; 28(4): 733-41, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25620182
9.
Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemia.
J Endocrinol Invest
; 35(2): 154-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21532330
10.
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues.
J Endocrinol Invest
; 33(9): 663-70, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20595800
11.
Octreotide-LAR vs lanreotide-SR as first-line therapy for acromegaly: a retrospective, comparative, head-to-head study.
J Endocrinol Invest
; 31(11): 956-65, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19169050
12.
A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients.
J Endocrinol Invest
; 30(6): 497-506, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17646725
13.
Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compression.
Eye (Lond)
; 29(6): 797-802, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25853400
14.
The role of somatostatin receptors in the medical treatment of acromegaly.
Dig Liver Dis
; 36 Suppl 1: S55-9, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15077912
15.
[Somatostatin analogs in the clinical management of pituitary neoplasms]. / Gli analoghi della somatostatina nell'inquadramento clinico della patologia ipofisaria.
Minerva Endocrinol
; 26(3): 181-91, 2001 Sep.
Artigo
em Italiano
| MEDLINE | ID: mdl-11753242
16.
Severe systemic complications of acromegaly.
J Endocrinol Invest
; 28(5 Suppl): 65-77, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16114280
17.
New perspectives in the medical treatment of acromegaly.
J Endocrinol Invest
; 28(11 Suppl International): 58-66, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16625847
18.
Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.
J Endocrinol Invest
; 28(5): 440-8, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16075928
19.
The use of a GH receptor antagonist in patients with acromegaly resistant to somatostatin analogs.
J Endocrinol Invest
; 26(10 Suppl): 53-6, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-15497660
20.
Role of somatostatin analogs in the management of non-functioning neuroendocrine tumors.
J Endocrinol Invest
; 26(8 Suppl): 82-8, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-15233220